Agree that the last point contradicts the others. I believe he was referring to in-house NTA commentary that could've been announced a month ago - had it been made, it would've been worthless anyway IMO.
- Forums
- ASX - By Stock
- HML
- Ann: Market Update - Preliminary Final Report
Ann: Market Update - Preliminary Final Report, page-165
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HML (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online